We offer several glutathione treatments because every patient has different goals, schedules, and preferences
The regulatory picture: What changed, and what does it mean for you
Exenatide (Byetta/Bydureon): Exenatide is an earlier-generation GLP-1 that is currently less expensive than semaglutide, but it needs to be administered more frequently and doesn't appear to have the same results in terms of weight loss and blood sugar control
compounded saves roughly $3,000/year vs that - Brand Zepbound at $400/month via LillyDirect is $4,800/year
Ellepola K, Truong T, Liu Y, Lin Q, Lim TK, Lee YM et al
A recent meta-analysis highlighted that females generally achieve greater weight loss than males when treated with GLP-1 RAs [55]